NBSE [NASD]
NeuBase Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.04 Insider Own2.50% Shs Outstand32.28M Perf Week6.32%
Market Cap7.74M Forward P/E- EPS next Y-0.33 Insider Trans0.00% Shs Float30.02M Perf Month3.46%
Income-33.80M PEG- EPS next Q-0.15 Inst Own37.20% Short Float / Ratio1.01% / 1.11 Perf Quarter-11.38%
Sales- P/S- EPS this Y-11.70% Inst Trans-6.04% Short Interest0.30M Perf Half Y-81.38%
Book/sh0.72 P/B0.33 EPS next Y26.70% ROA-75.70% Target Price7.00 Perf Year-83.86%
Cash/sh0.72 P/C0.33 EPS next 5Y4.00% ROE-97.30% 52W Range0.17 - 2.08 Perf YTD27.29%
Dividend- P/FCF- EPS past 5Y37.20% ROI- 52W High-88.36% Beta1.05
Dividend %- Quick Ratio5.90 Sales past 5Y- Gross Margin- 52W Low40.75% ATR0.03
Employees37 Current Ratio5.90 Sales Q/Q- Oper. Margin- RSI (14)51.32 Volatility12.49% 13.31%
OptionableNo Debt/Eq0.00 EPS Q/Q-8.30% Profit Margin- Rel Volume0.23 Prev Close0.24
ShortableYes LT Debt/Eq0.00 EarningsDec 22 AMC Payout- Avg Volume275.20K Price0.24
Recom3.00 SMA20-1.98% SMA507.38% SMA200-61.39% Volume34,566 Change0.88%
Feb-12-21Reiterated H.C. Wainwright Buy $15 → $18
Jun-16-20Initiated RBC Capital Mkts Outperform $16
Feb-07-20Initiated Guggenheim Buy
Feb-06-20Initiated Guggenheim Buy
Nov-21-19Initiated Oppenheimer Outperform $14
Sep-24-19Initiated BTIG Research Buy $15
Dec-29-22 05:53PM
Dec-21-22 08:00AM
Oct-21-22 08:00AM
Oct-14-22 04:05PM
Sep-22-22 04:05PM
08:00AM Loading…
Aug-11-22 08:00AM
Aug-08-22 09:57AM
Jun-29-22 08:01AM
Jun-01-22 07:00AM
May-17-22 07:00AM
May-12-22 05:00PM
10:53AM
May-02-22 04:30PM
Mar-13-22 07:00PM
Mar-07-22 08:00AM
08:00AM Loading…
Feb-28-22 08:00AM
Feb-10-22 07:00PM
Feb-01-22 10:44AM
Jan-11-22 11:34AM
Jan-10-22 04:02PM
Jan-05-22 04:02PM
Dec-23-21 04:01PM
Nov-03-21 04:05PM
Nov-01-21 01:12PM
Oct-05-21 08:00AM
Sep-28-21 04:05PM
Sep-21-21 04:54PM
Sep-15-21 04:05PM
Sep-14-21 08:00AM
Sep-01-21 04:05PM
08:45AM Loading…
Aug-31-21 08:45AM
Aug-12-21 04:01PM
Jun-30-21 05:07AM
Jun-08-21 12:30PM
Jun-02-21 09:00AM
May-25-21 08:00AM
May-20-21 08:00AM
May-14-21 12:31PM
May-13-21 04:05PM
May-12-21 09:00AM
Apr-28-21 04:27AM
Apr-27-21 08:00AM
Apr-26-21 04:01PM
Apr-22-21 09:07AM
Apr-21-21 04:01PM
Apr-14-21 07:00AM
Apr-08-21 08:00AM
Mar-19-21 05:33AM
Mar-16-21 08:00AM
Mar-09-21 07:00AM
Feb-11-21 04:01PM
Jan-28-21 08:00AM
Jan-22-21 12:14AM
Jan-11-21 06:00AM
Dec-23-20 04:05PM
Dec-18-20 11:35AM
Dec-16-20 06:30AM
Dec-02-20 06:23PM
08:00AM
Nov-23-20 08:00AM
Nov-18-20 01:46AM
Nov-17-20 08:00AM
Nov-10-20 08:00AM
Oct-26-20 08:15AM
Oct-20-20 10:09AM
Oct-13-20 08:00AM
Sep-28-20 08:00AM
Sep-17-20 08:30AM
Sep-08-20 08:00AM
Aug-31-20 05:00PM
Aug-24-20 05:00PM
Aug-20-20 01:09PM
Aug-13-20 04:01PM
Aug-06-20 01:43PM
Jun-10-20 04:20PM
May-15-20 08:48AM
Apr-30-20 04:05PM
Apr-28-20 09:44AM
Apr-27-20 04:01PM
Mar-31-20 07:01AM
Dec-02-19 08:00AM
Nov-25-19 08:00AM
Nov-24-19 04:30PM
Nov-12-19 09:16AM
Oct-17-19 08:00AM
Oct-11-19 08:00AM
Sep-26-19 09:08AM
Sep-21-19 11:25AM
Sep-09-19 08:39AM
Aug-14-19 04:05PM
Aug-07-19 08:00AM
Jul-30-19 08:00AM
Jul-24-19 08:00AM
Jul-15-19 10:20AM
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stephan Dietrich ACEOSep 28Option Exercise0.00750,000825816,775Sep 30 07:45 PM
Mann William RolandChief Operating OfficerMar 30Buy1.926,20011,90411,200Apr 01 04:16 PM
Branning Todd P.Chief Financial OfficerMar 18Buy1.8110,00018,10030,000Mar 21 04:06 PM
Branning Todd P.Chief Financial OfficerMar 17Buy1.7410,00017,40020,000Mar 18 04:11 PM
Branning Todd P.Chief Financial OfficerMar 16Buy1.6210,00016,20010,000Mar 18 04:11 PM
RICHMAN ERIC IDirectorMar 04Buy1.621,0001,62044,960Mar 07 07:13 PM
RICHMAN ERIC IDirectorMar 03Buy1.721,3002,23643,960Mar 07 07:13 PM
RICHMAN ERIC IDirectorMar 01Buy1.581,5802,49642,660Mar 07 07:13 PM